Clinical Trial Update: Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 Study [NA]

View source ↗

Summary

An open-label, single-arm Phase 2 trial is evaluating radiotherapy for BCG-unresponsive non-muscle-invasive bladder cancer with carcinoma in situ across multipl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma in Situ of Bladder
• Non-muscle Invasive Bladder Cancer

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Non-Muscle Invasive Bladder Cancer | NA | Status: NOT_YET_RECRUITING